# Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

> **NCT00806195** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 7744 (actual)

## Conditions studied

- Meningitis
- Meningococcal Infection

## Interventions

- **BIOLOGICAL:** MenACWY-CRM197
- **BIOLOGICAL:** DTaP (Diptheria, Tetanus, Pertussis) Vaccine
- **BIOLOGICAL:** Hib (Haemophilus influenza b) Vaccine
- **BIOLOGICAL:** IPV (Inactivated Polio Vaccine) Vaccine
- **BIOLOGICAL:** Pneumococcal conjugate Vaccine
- **BIOLOGICAL:** MMR (Measles, Mumps, and Rubella) Vaccine
- **BIOLOGICAL:** Varicella Vaccine
- **BIOLOGICAL:** Hepatitis A Virus

## Key facts

- **NCT ID:** NCT00806195
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-11
- **Target enrollment:** 7744 (ACTUAL)
- **Last updated:** 2013-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00806195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00806195, "Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00806195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*